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Recently, oxidative stress has been reported to contribute an important role in the decline of physical function as age advances.
Numerous antioxidants can improve both physical and psychological performances resulting in the increase of health-related
quality of life (HQOL). Therefore, we hypothesized that Centella asiatica, a medicinal plant reputed for nerve tonic, strength
improvement and antioxidant activity, could improve the physical performance and HQOL especially in the physical satisfaction
aspect, of the healthy elderly volunteer. To test this hypothesis, a double-blind, placebo-controlled, randomized trial was
performed. Eighty healthy elderly were randomlyassigned to receive placebo or standardized extract of C. asiatica at doses of 250,
500 and 750mg once daily for 90 days. The subjects were evaluated to establish baseline data of physical performance using 30-s
chair stand test, hand grip test and 6-min walk test. The health-related quality of life was assessed using SF-36. These assessments
were repeated every month throughout the 3-month experimental period using the aforementioned parameters. Moreover, 1
monthafter thecessationof C. asiatica treatment, all subjects were alsoevaluatedusing theseparameters again.The results showed
that after 2 months of treatment, C. asiatica at doses of 500 and 750mg per day increased lower extremity strength assessed via
the 30-s chair stand test. In addition, the higher doses of C. asiatica c o u l di m p r o v et h el i f es a t i s f a c t ion subscale within the physical
function subscale. Therefore, the results from this study appear to support the traditional reputation of C. asiatica on strength
improvement, especially in the lower extremities of the elderly. C. asiatica also possesses the potential to be a natural resource for
vigor and strength increase, in healthy elderly persons. However, further research is essential.
1.Introduction
As age advances, the functional ﬁtness declines and results
in poor quality of life [1, 2]. This situation has an enormous
impact onthesocio-economic status. The need forenhanced
quality of life is increasing in its importance. Recent studies
have shown the strong correlation between antioxidant
consumption and physical performance in the elderly.
Antioxidant consumption improved physical performance
and physical strength [3]. Substances possessing antioxidant
activity can have a positive eﬀect on psychological stress [4].
Studies have also shown that the poor mental health score
assessed using SF-36, and poor quality of life was associated
with the low plasma level of antioxidants such as vitamin
E[ 5]. Therefore, the development of food supplements to
enhance the quality of life and physical performance of the
elderly, has gained more concentration in recent times.
Centella asiatica (L) urban, a creeping plant in the family
of Apiaceae, is found almost all over the world, including
China, India and Thailand. This plant has been used in
traditional folkhealingfor theailments ofvarious conditions
including headache, body ache, insanity, asthma, leprosy,
eczemas, and ulcersand woundhealing [6,7].Thisplantalso
provides numerous beneﬁcial eﬀects for the nervous system2 Evidence-Based Complementary and Alternative Medicine
such as anxiolytic[8] and anti-depression [9]. Recentstudies
both in animals and in human volunteers demonstrated that
this medicinal plant could enhance cognitive function [10–
13], as well as possessing antioxidant activity [14]. Moreover,
it has been believed to enhance vigor and strength in the
southern part of India.
Based on its reputation to improve both psychological
and physical performances, and its antioxidant properties,
the hypothesis that C. asiatica extract would have a positive
eﬀect on the physical strength and health-related quality of
life, for the healthy elderly, was properly focused.
2.Methods
2.1. Participants. A total of 80, healthy, elderly volunteers,
4 male and 76 females (mean age 65.05 ± 3.56 years)
were recruited to participate in this study. The Khon
Kaen University, Faculty of Medicine, Ethics Committee,
approved the study (ethical number HE490208). Inclusion
criteria included healthy, elderly persons between the ages
of 55 and 80, who were Thai Nationals dwelling in the
Northeast Region of Thailand. Exclusion criteria included
any history of cardiovascular diseases, respiratory diseases,
neuropsychological diseases, head injury, diabetes, cancer,
alcohol addiction, smokers of more than 10 pieces per day.
Any persons taking prescribed and non-prescribed drugs or
nutraceutical compounds inﬂuencing the function of the
nervous system were also excluded.
Priortoparticipation,each volunteersignedaninformed
consent form and completed a medical health questionnaire.
All recruited subjects were screened for medical health issues
again, by the study physician, to assure the health status of
all subjects prior to participation in the study. All subjects
underwent an electrocardiogram, blood pressure and blood
sugar evaluation.
All subjects also participated in an extensive medical
evaluationprocesstoascertainsubjectsuitabilityforentering
the double-blind phase of the trial. All subjects were free
of any herbal or prescribed medication that interfered or
altered the function ofthe nervous system. Habitualsmokers
consuming more than 10 cigarettes per day were excluded
fromthisstudy.Allparticipantswererequestedand agreedto
abstain from, caﬀeine containing products, throughout each
studyday,andalcoholforaminimumof12hpriortothetest
sessions.
2.2. Centella asiatica Preparation. A standardized aqueous
extract of C. asiatica was prepared as described in patty
patent (no. 4721, Thailand) by the Center for Research and
Development of Herbal Health Product, Faculty of Phar-
maceutical Sciences, Khon Kaen University. All C. asiatica
used in this study was obtained from Tambon Sila, Khon
Kaen Province. The plant was authenticated and kept as
voucherspecimen by theFacultyofPharmaceutical Sciences,
Khon Kaen University. Standardization and conformity of
the extract was assured by strict in-process controls during
manufacture and complete analytical control of the resulting
dry extract. A-day capsule contained a specialized aerial part
extractcontainingtotalphenoliccontentequivalenttotannic
acid = 29.9mg/g. In addition, the extract also contained
asiaticoside and asiatic acid were presented at concentration
of 1.09 and 48.89mg/g of crude extract, respectively
2.3. Procedures and Treatments. This study was a pilot study
conducted as a 12-week, double-blind, placebo-controlled,
randomized trial. A random list of numbers was generated
by computer. After being randomly assigned to various
treatment groups, each participant received one capsule of
placebo or C. asiatica extract at various dosesof250, 500and
750mg, once daily. Placebo and C. asiatica capsules had the
same color, texture, size and smell.
This study assesses the physical performance consisting
of strength and endurance. All participants were assessed for
baseline data concerning physical ﬁtness using a modiﬁed
test of Rogers et al. [15] and Jones et al. [16]. The method of
Rogers et al. assessed only the physical parameters associated
with fall risk in older persons which consist of tests for
balance assessment, walking velocity and muscle strength.
This study assessment consists of:
(i) Thirty-second chair stand test assessing lower ex-
tremity strength.
(ii) Hand grip evaluating upper extremity strength.
(iii) Six-minute walk test assessing aerobic endurance.
This study modiﬁed the method of Rogers et al. by using
only the 30-s chair stand test and hand grip test to evaluate
strength. This study also includes a 6-min walk test to assess
endurance. All three of the tests that are used in this study
are indicators of function and overall physical performance
in the elderly.
Test subjects were assessed on their quality of life using
the health quality of life questionnaire SF-36. Additional
data pertaining to subjects social relationships, memory and
learning were also collected. Subjects were assessed on their
quality of life at a monthly interval, for the entire 3 month
study. In addition, subjects were again assessed using the
above mentioned parameters at 1 month post cessation of
C. asiatica treatment. The code for study allocation was only
broken when the last participant completed the entire follow
up. Staﬀ involved in the collection of the study’s endpoints
were instructed to follow a rigorous protocol and not to
discuss any issues related to the use of medication. The
review of compliance with medication and side-eﬀects was
performed independentlyby the investigators, who were also
blinded to group allocation. Adverse eﬀects were assessed
during every study visit. Subjects were requested to call
the study center if they experienced any medical problems
during the 90-day study period.
2.4. Quality of Life Assessment. Health-related quality of life
was assessed by SF-36 and additional information collected
concerning subjects’ social relationships, memory and learn-
ing. Evaluation of the SF-36 was done by an investigator who
was blinded to the subjects. In brief, the SF-36 is a generic
health survey designed to assess aspects of health that areEvidence-Based Complementary and Alternative Medicine 3
not disease, treatment, or age speciﬁc. The SF-36 is a generic
multidimensional instrument consisting of eight multi-
item components representing physical functioning (PF; the
extent to which health limits physical activities, such as self
care, walking and climbing stairs); role functioning physical
(RP; the extent to which physical health interferes with work
or other daily activities); bodily pain (BP; the intensity of
pain and the eﬀect of pain on normal work, both inside and
outside the home); general health perceptions (GH; personal
evaluations of current health, health outlook and resistance
to illness); vitality (VT; feeling full of energy rather than
tired and worn out); social functioning (SF; the extent to
which physical health or emotional problems interfere with
normal social activities); rolefunctioning emotional (RE;the
extent to which emotional problems interfere with work or
daily activities); mental health (MH; general mental health
including depression, anxiety, behavioral-emotional control,
and general positive aﬀect) [17]. In this study, SF-36 scores
in physical functioning aspects were converted to a scale of
0–100, a higher score indicating a better quality of life.
2.5. Statistical Analysis. All data are expressed as means ±
SD. Comparisons between placebo and various doses of C.
asiatica at diﬀerent time points were made using repeated
measurement analysis of variance (repeated-ANOVA). Sta-
tistical signiﬁcance was set at P-value < .05.
3.Results
3.1. Characteristics of Subjects. Eighty elderly subjects par-
ticipated in this study. The trial commenced with 76 female
and 4 male volunteers. The entire study was conducted and
completed with all 80 original study subjects. The baseline
data concerning characteristics of subjects in all groups are
shown in Table 1.N os i g n i ﬁ c a n td i ﬀerences of parameters
among various groups were observed.
3.2. Physical Fitness. The eﬀects of C. asiatica on the 30-s
chair stand test and 6-min walk test are shown in Table 2,
with the eﬀect of C. asiatica on the grip strength test shown
in Table 3.I tw a sf o u n dt h a tC. asiatica extract at doses
of 500 and 750mg per day, showed improvement in the
30-s chair stand test results, signiﬁcantly, at 2 months of
treatment and the signiﬁcance was still observed at 3 months
of treatment (F(0.0500, 3.57) = 23.3794, P < .0001). When
the treatment was prolonged to 3 months, the low dose
of C. asiatica could also improve the 30-s chair stand test
(F(0.0500, 3.57) = 5.2662, P = .0028) when compared with
the baseline data. No time window of exposure dependent
and dose dependent was observed on this parameter. The
plantextract atalldoselevelsusedinthisstudyfailedtoshow
signiﬁcant improvement on the 6-min walk test and hand
strengthtest.Nosigniﬁcantchangesoftheseparameterswere
observed at 1 month post cessation of C. asiatica treatment
for all dosage ranges used in this study. The data also showed
that at 1 month post cessation of C. asiatica treatment, all
signiﬁcant changes disappeared.
3.3. Quality of Life. The eﬀect of C. asiatica on life satisfac-
tion was assessed using the QOL questionnaire and the data
is shown in Table 4.A f t e r2m o n t h so fC. asiatica treatment,
signiﬁcant improvement of the physical functioning subscale
of SF-36 was observed (F(0.0500, 4.76) = 2.2741, P =
.0690) when compared with the pre-dose score. However, 1
month post cessation of C. asiatica, no signiﬁcant changes of
physical domain of life satisfaction were observed.
4.Discussion
This study is the ﬁrst study to show that C. asiatica can
improve the performance in the 30-s chair stand test results,
which is indicative of improvement in lower extremity
strength. It was found that after the administration of
C. asiatica extract at a period of 2 and 3 months, the
performance of the elderly in 30-s chair stand test improved.
Previous study demonstrated that as the age advanced,
the capacity of skeletal muscle to use oxygen decreased. In
addition, the ﬁber diameter of skeletal muscle and its mass
also decreased [18]. Abundant factors have been claimed
to contribute to the important role of age-related skeletal
muscle loss, including the increase of free radicals. Data
obtained from animal study showed that the activity of
glutathione peroxidase enzyme in skeletal muscle decreased
[19]while thereactiveoxygenspecies(ROS)increased dueto
t h ed e c r e a s eo fm i t o c h o n d r i a lf u n c t i o n[ 20]. C. asiatica was
reported to improve oxidative stress [10].
Recently, it was also shown that the increase of muscle
blood ﬂow played an important role on the metabolic impli-
cations, which in turn inﬂuenced the functional capacity
of the muscle [21]. C. asiatica w a sa l s oa b l et oi n c r e a s e
blood ﬂow [22]. Taking all data together, we suggest that
the possible underlying mechanism of C. asiatica to improve
the muscle strength of lower extremities might occur partly
via its antioxidant activity and partly via the increase of
bloodﬂowtoskeletalmuscle(Figure 1).However,theprecise
underlying mechanism will require further study.
It was shown that C. asiatica could improve only the
strength of the muscle of lower extremities but not that
of the upper extremities. The possible explanation for this
phenomenon might be related tothe diﬀerential distribution
of type I and II skeletal muscle. It had been previously
reported that muscle of the lower extremities appeared to
contain more type I muscle ﬁber, which contained higher
vascular supply, than the muscle of the upper extremities.
The health-related quality of life (HRQOL) in this study
was assessed using the SF-36 questionnaire. Health is deﬁned
as a dynamic state of human wellbeing characterized by a
physical, mental and social potential aﬀected by “health” as
deﬁned above. HRQL has been introduced to assess people’s
health status. To date, a number of questionnaires have been
developed to evaluate HRQL, and the 36-item Short Form
Health Survey (SF-36) is the most commonly used. The SF-
36 has been proven useful in monitoring population health,
estimating the burdensof diﬀerent diseases, monitoring out-
come in clinical practice and evaluating medical treatment
eﬀects. It has been translated into many languages with its
content examined cross cultures [23–26].4 Evidence-Based Complementary and Alternative Medicine
Table 1: Baseline characteristic of subjects.
Baseline data Placebo CA250 CA500 CA750
Age (years) 65.70 ± 4.88 64.60 ± 4.54 64.20 ± 5.11 66.75 ±4.73 F(0.0500, 3.76) = 1.1380, P = .3392
Education (years) 10.90 ± 5.93 11.70 ± 5.55 11.25 ± 5.32 11.60 ± 6.08 F(0.0500, 3.76) = 0.0806, P = .9704
Blood pressure
(mmHg)
120.75 ± 8.48/
80.20 ± 6.35
116.40 ± 11.43/
76.45 ± 7.04
119.90 ± 11.36/
80.35 ± 7.62 121.80 ±9.99 F(0.0500, 3.76) = 1.0165, P = .3902
79.20 ±6.12 F(0.0500, 3.76) = 1.4091, P = .2467
Blood sugar 94.75 ± 12.49 92.45 ± 5.89 93.20 ± 7.32 95.20 ±12.40 F(0.0500, 3.76) = 0.3351, P = .8000
Body mass index 24.54 ± 4.33 22.87 ± 3.24 23.25 ± 2.50 23.75 ±3.03 F(0.0500, 3.76) = 0.9312, P = .4299
Subjects were measured baseline characteristic.Data are presented as mean ± SD. P-a n dF-values were compared between groups (n = 20/group).
Table 2: Eﬀect of C. asiatica on physical ﬁtness measured by 30-s chair stand test and 6-min walk test.
Items
Pre-dose baseline score Post-dose score
1m o n t h 2m o n t h 3m o n t h D e l a y
30-s chair stand
test (times)
16.05 ±2.72 16.10 ± 3.67
Placebo 15.85 ± 2.87 15.65 ± 2.80 15.70 ± 2.99 F(0.0500, 3.57) = 0.3352, F(0.0500, 1.19) = 0.1351,
P = .7999 P = .7172
20.35 ±4.82
a,∗∗ 18.60 ± 5.96
CA250 16.85 ± 4.21 18.40 ± 4.07 18.35 ± 4.85 F(0.0500, 3.57) = 5.2662, F(0.0500, 1.19) = 2.2391,
P = .0028 P = .1510
20.35 ±3.66b,∗∗ 17.30 ± 4.03
CA500 16.80 ± 4.36 17.75 ± 3.80 19.90 ± 4.10
a,∗∗ F(0.0500, 3.57) = 23.3794, F(0.0500, 1.19) = 1.3768,
P<. 0001 P = .2551
21.00 ±4.48
b,∗∗∗ 17.90 ±5.93
CA750 16.80 ± 3.09 17.45 ± 3.53 18.55 ±3.17
a,∗ F(0.0500, 3.57) = 13.9752, F(0.0500, 1.19) = 0.9200,
P<. 0001 P = .3495
6m i nw a l kt e s t
(meters)
518.35 ±59.62 510.55 ±78.06
Placebo 515.60 ± 42.18 509.45 ± 55.78 504.95 ± 57.32 F(0.0500, 3.57) = 1.0645, F(0.0500, 1.19) = 0.1759,
P = .3714 P = .6796
535.60 ±52.40 519.25 ±81.86
CA250 517.60 ± 59.75 527.95 ± 42.34 524.25 ± 49.77 F(0.0500, 3.57) = 1.6551, F(0.0500, 1.19) = 0.0155,
P = .1869 P = .9022
521.35 ±66.20 512.00 ±67.95
CA500 509.50 ± 57.38 517.00 ± 64.62 523.10 ± 67.8 F(0.0500, 3.57) = 1.8655, F(0.0500, 1.19) = 0.0355,
P = .1457 P = .8526
524.75 ±80.68 520.55 ±87.65
CA750 511.75 ± 54.12 517.80 ± 75.67 529.05 ± 82.27 F(0.0500, 3.57) = 1.2784, F(0.0500, 1.19) = 0.5046,
P = .2905 P = .4861
Subjects were measured physical ﬁtness measured by 30-s chair stand test and 6-min walk test. Data are presented as mean ± SD. P-a n dF-values were
compared between pre-dose baseline score and post-dose 1, 2, 3 month and 1 month after cessation of treatment (n = 20/group).a,bP-value <.01 and.001
compared with pre-dose baseline score, respectively.
∗, ∗∗, ∗∗∗P-value <. 05, .01 and .001 compared with placebo treated group, respectively.
In addition, SF-36 has been used as an instrument for
assessing qualityoflifeworld-wide. Normativedatahavealso
been obtained in many countries [27]. The SF-36 consists
of eight multi-item components representing physical func-
tioning,rolefunctioningphysical,bodilypain,generalhealth
perceptions, vitality, social functioning and role functioning
emotional and mental health [17]. However, the main focus
in this study was the physical functioning. The results from
this study showed that C. asiatica improved the satisfaction
score of physical ﬁtness items. The improvement in physical
ﬁtness was observed only after 2 months of C. asiatica
treatment at a high dose. Moreover, the signiﬁcance was still
observed when the treatment duration was increased further
to 3 months. The changes observed using this tool wereEvidence-Based Complementary and Alternative Medicine 5
Table 3: Eﬀect of C. asiatica on physical ﬁtness measured by hand grip.
Hand strength
Pre-dose baseline score Post-dose score
1m o n t h 2m o n t h 3m o n t h D e l a y
Left side (kg)
23.65 ±3.93 23.85 ±4.33
Placebo 23.05 ± 4.69 22.95 ± 4.57 23.48 ± 4.46 F(0.0500, 3.57) = 0.6867, F(0.0500, 1.19) = 3.5145,
P = .563 P = .0763
23.03 ±6.19 22.20 ±3.11
CA250 21.55 ± 3.45 22.28 ± 2.96 22.70 ± 2.34 F(0.0500, 3.57) = 1.5077, F(0.0500, 1.19) = 2.8391,
P = .2223 P = .1084
23.25 ±4.98
23.93 ±5.64 F(0.0500, 1.19) = 1.6032,
CA500 24.80 ± 7.88 23.90 ± 6.59 22.98 ± 5.30 F(0.0500, 3.57) = 1.3040, P = .2208
P = .2820 24.80 ±6.17
25.75 ±6.45 F(0.0500, 1.19) = 0.0293,
CA750 24.85 ± 6.29 25.50 ± 6.55 26.15 ± 7.30 F(0.0500, 3.57) = 2.2607, P = .8660
P = .0911
Right side (kg)
24.15 ±5.09 23.95 ±5.31
Placebo 23.43 ± 5.63 23.33 ± 5.24 24.05 ± 5.44 F(0.0500, 3.57) = 1.3691, F(0.0500, 1.19) = 2.1713,
P = .2614 P = .1570
23.35 ±2.50
23.30 ±3.11 F(0.0500, 1.19) = 0.0381,
CA250 23.40 ± 2.67 24.05 ± 3.78 23.38 ± 3.01 F(0.0500, 3.57) = 1.2931, P = .8474
P = .2856 24.00 ±5.99
25.93 ±6.09 F(0.0500, 1.19) = 3.5531,
CA500 26.58 ± 7.95 24.7 ± 6.32 24.38 ± 5.16 F(0.0500, 3.57) = 2.0774, P = .0748
P = .1133 25.25 ±6.34
25.45 ±5.27 F(0.0500, 1.19) = 2.8239,
CA750 26.18 ± 5.53 26.40 ± 5.44 26.98 ± 5.41 F(0.0500, 3.57) = 2.0055, P = .1092
P = .0617
Subjects were measured physical ﬁtness by hand grip. Data are presented as mean ± SD. P-a n dF-values were compared between pre-dose baseline score and
post-dose 1, 2, 3 month and 1 month after cessation of treatment (n = 20/group).
Table 4: Eﬀect of various doses of C. asiatica on the satisfaction physical ﬁtness score which assessed using QOL questionnaire in healthy
elderly volunteer.
Aspect
Pre-dose baseline score Post-dose
1m o n t h 2m o n t h 3m o n t h D e l a y
Physical
Functioning
80.00 ±13.28
Placebo 84.50 ± 11.96 82.00 ± 13.07 80.13 ± 9.68 79.00 ± 9.26 F(0.0500, 4.76) = 2.3261,
P = .0639
80.50 ±15.25
CA250 78.25 ± 14.60 77.63 ± 16.13 80.75 ± 10.26 78.75 ± 12.13 F(0.0500, 4.76) = 1.0113,
P = .4070
81.63 ±13.01
CA500 84.13 ± 11.59 82.88 ± 10.74 84.63 ± 10.86 86.00 ± 7.75∗ F(0.0500, 4.76) = 2.2900,
P = .0674
80.50 ±10.66
CA750 78.89 ± 9.46 80.4 ± 9.9 82.88 ± 7.79b 83.38 ± 7.53a F(0.0500, 4.76) = 2.2741,
P = .0690
Subjects were measured the satisfaction score which assessed using QOL questionnaire. Data are presented as mean ± SD. P-a n dF-values were compared
between pre-dose baseline score and post-dose score for 1, 2, 3 month and 1 month after the cessation of C. asiatica treatment (n = 20/group).
a,bP-value < .05 and .001 compared with pre-dose baseline score, respectively.
∗P-value < . 0 5c o m p a r e dw i t hp l a c e b ot r e a t e dg r o u p .6 Evidence-Based Complementary and Alternative Medicine
C. asiatica
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Scavenging
enzyme
Oxidative stress
Blood ﬂow
Mitochondria
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to use O2
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Figure 1: Eﬀect of C. asiatica on the skeletal muscle of lower
extremities. ROS: reactive oxygen species, O2:o x y g e n ,L E s :l o w e r
extremities.
also correspondent with the alteration of physical activity.
Therefore, this plant has a potential to improve physical
ﬁtness in healthy elderly.
The results obtained from this study failed to show
the dose dependent manner. This might be related to the
masking eﬀect of other ingredients existing in the crude
extract, of C. asiatica extract. Since the C. asiatica used in
this study was the crude extract, the increased concentration
of this plant extract might also increase the concentration of
both active and non-active ingredients. Thus, the non-active
ingredients might mask the eﬀect of the active ingredient.
In conclusion,our study clearly demonstrated the poten-
tial of C. asiatica to improve muscle strength, especially the
muscle of the lower extremities. C. asiatica might be useful
as a natural resource in the development of functional foods
improving the daily physical activity in the healthy elderly.
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